BHST NASDAQ
BioHarvest Sciences Inc.
1W: -0.7%
1M: -23.7%
3M: -49.8%
YTD: -72.2%
1Y: -84.3%
$1.47
-0.02 (-1.34%)
Weekly Expected Move ±6.0%
$1
$1
$1
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$25M
+98.8% ▲
5Y CAGR: +158.6%
Gross Profit
$14M
+147.5% ▲
5Y CAGR: +243.9%
Operating Income
-$7M
+29.9% ▲
Net Income
-$13M
-2.8% ▼
EPS (Diluted)
$-0.80
+14.0% ▲
EBITDA
-$10M
+0.4% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $396K | $2M | $5M | $13M | $25M |
| YoY Growth | +81.7% | +430.8% | +161.6% | +130.5% | +98.8% |
| Cost of Revenue | $258K | $1M | $4M | $7M | $11M |
| Gross Profit | $138K | $670K | $1M | $6M | $14M |
| Gross Margin | 34.8% | 31.9% | 22.2% | 44.5% | 55.4% |
| R&D Expenses | $1M | $4M | $2M | $3M | $5M |
| SG&A Expenses | $4M | $5M | $9M | $12M | $16M |
| Operating Expenses | $6M | $9M | $12M | $16M | $21M |
| Operating Income | -$6M | -$8M | -$11M | -$10M | -$7M |
| Operating Margin | -1557.1% | -403.9% | -193.0% | -78.6% | -27.7% |
| Interest Expense | $536K | $805K | $1M | $2M | $2M |
| Income Before Tax | -$7M | -$10M | -$11M | -$13M | -$13M |
| Tax Expense | $0 | $0 | $0 | $0 | $8K |
| Net Income | -$7M | -$10M | -$11M | -$13M | -$13M |
| Net Margin | -1662.6% | -467.5% | -204.4% | -99.1% | -51.3% |
| EPS (Diluted) | $-0.70 | $-0.70 | $-0.70 | $-0.93 | $-0.80 |
| EBITDA | -$6M | -$9M | -$9M | -$10M | -$10M |
| Shares Outstanding | 10M | 12M | 13M | 14M | 16M |